Selected research
Market Outlook & Growth Opportunities
Global CAR-T Cell Service Market Outlook and Growth Opportunities 2026
Market perspective
The global CAR-T Cell Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for CAR-T Cell Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CAR-T Cell Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CAR-T Cell Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the CAR-T Cell Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the CAR-T Cell Service market include Aurigene Pharmaceutical Services Ltd, Cellipont Bioservices, ProBio, Creative Biolabs, Charles River Laboratories, Cytiva, Sino Biological, Inc, Miltenyi Biotec and ProMab Biotechnologies, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global CAR-T Cell Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CAR-T Cell Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CAR-T Cell Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global CAR-T Cell Service market.
CAR-T Cell Service Segment by Company
Aurigene Pharmaceutical Services Ltd
Cellipont Bioservices
ProBio
Creative Biolabs
Charles River Laboratories
Cytiva
Sino Biological, Inc
Miltenyi Biotec
ProMab Biotechnologies, Inc
Creative Biogene
BPS Bioscience, Inc
Reaction Biology
Cusabio Technology LLC
Oncodesign Services
ACROBiosystems
Kite Pharma, Inc
sartorius
WuXi ATU Co
CAR-T Cell Service Segment by Type
Development Services
Manufacturing Services
Other
CAR-T Cell Service Segment by Application
Clinical Research
Clinical Treatment
Other
CAR-T Cell Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global CAR-T Cell Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the CAR-T Cell Service key companies, revenue, market share, and recent developments.
3. To split the CAR-T Cell Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions CAR-T Cell Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify CAR-T Cell Service significant trends, drivers, influence factors in global and regions.
6. To analyze CAR-T Cell Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CAR-T Cell Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CAR-T Cell Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CAR-T Cell Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CAR-T Cell Service industry.
Chapter 3: Detailed analysis of CAR-T Cell Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of CAR-T Cell Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of CAR-T Cell Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Development Services
- Manufacturing Services
- Other
Applications
- Clinical Research
- Clinical Treatment
- Other
Companies covered
- Aurigene Pharmaceutical Services Ltd
- Cellipont Bioservices
- ProBio
- Creative Biolabs
- Charles River Laboratories
- Cytiva
- Sino Biological, Inc
- Miltenyi Biotec
- ProMab Biotechnologies, Inc
- Creative Biogene
- BPS Bioscience, Inc
- Reaction Biology
- Cusabio Technology LLC
- Oncodesign Services
- ACROBiosystems
- Kite Pharma, Inc
- sartorius
- WuXi ATU Co
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global CAR-T Cell Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global CAR-T Cell Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 CAR-T Cell Service Market Dynamics
- 2.1 CAR-T Cell Service Industry Trends
- 2.2 CAR-T Cell Service Industry Drivers
- 2.3 CAR-T Cell Service Industry Opportunities and Challenges
- 2.4 CAR-T Cell Service Industry Restraints
3 CAR-T Cell Service Market by Company
- 3.1 Global CAR-T Cell Service Company Revenue Ranking in 2025
- 3.2 Global CAR-T Cell Service Revenue by Company (2021-2026)
- 3.3 Global CAR-T Cell Service Company Ranking (2024-2026)
- 3.4 Global CAR-T Cell Service Company Manufacturing Base and Headquarters
- 3.5 Global CAR-T Cell Service Company Product Type and Application
- 3.6 Global CAR-T Cell Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global CAR-T Cell Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 CAR-T Cell Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 CAR-T Cell Service Market by Type
- 4.1 CAR-T Cell Service Type Introduction
- 4.1.1 Development Services
- 4.1.2 Manufacturing Services
- 4.1.3 Other
- 4.2 Global CAR-T Cell Service Sales Value by Type
- 4.2.1 Global CAR-T Cell Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global CAR-T Cell Service Sales Value by Type (2021-2032)
- 4.2.3 Global CAR-T Cell Service Sales Value Share by Type (2021-2032)
5 CAR-T Cell Service Market by Application
- 5.1 CAR-T Cell Service Application Introduction
- 5.1.1 Clinical Research
- 5.1.2 Clinical Treatment
- 5.1.3 Other
- 5.2 Global CAR-T Cell Service Sales Value by Application
- 5.2.1 Global CAR-T Cell Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global CAR-T Cell Service Sales Value by Application (2021-2032)
- 5.2.3 Global CAR-T Cell Service Sales Value Share by Application (2021-2032)
6 CAR-T Cell Service Regional Value Analysis
- 6.1 Global CAR-T Cell Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global CAR-T Cell Service Sales Value by Region (2021-2032)
- 6.2.1 Global CAR-T Cell Service Sales Value by Region: 2021-2026
- 6.2.2 Global CAR-T Cell Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America CAR-T Cell Service Sales Value (2021-2032)
- 6.3.2 North America CAR-T Cell Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe CAR-T Cell Service Sales Value (2021-2032)
- 6.4.2 Europe CAR-T Cell Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific CAR-T Cell Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific CAR-T Cell Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America CAR-T Cell Service Sales Value (2021-2032)
- 6.6.2 South America CAR-T Cell Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa CAR-T Cell Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa CAR-T Cell Service Sales Value Share by Country, 2025 VS 2032
7 CAR-T Cell Service Country-level Value Analysis
- 7.1 Global CAR-T Cell Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global CAR-T Cell Service Sales Value by Country (2021-2032)
- 7.2.1 Global CAR-T Cell Service Sales Value by Country (2021-2026)
- 7.2.2 Global CAR-T Cell Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt CAR-T Cell Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt CAR-T Cell Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt CAR-T Cell Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Aurigene Pharmaceutical Services Ltd
- 8.1.1 Aurigene Pharmaceutical Services Ltd Company Information
- 8.1.2 Aurigene Pharmaceutical Services Ltd Business Overview
- 8.1.3 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Product Portfolio
- 8.1.5 Aurigene Pharmaceutical Services Ltd Recent Developments
- 8.2 Cellipont Bioservices
- 8.2.1 Cellipont Bioservices Company Information
- 8.2.2 Cellipont Bioservices Business Overview
- 8.2.3 Cellipont Bioservices CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Cellipont Bioservices CAR-T Cell Service Product Portfolio
- 8.2.5 Cellipont Bioservices Recent Developments
- 8.3 ProBio
- 8.3.1 ProBio Company Information
- 8.3.2 ProBio Business Overview
- 8.3.3 ProBio CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.3.4 ProBio CAR-T Cell Service Product Portfolio
- 8.3.5 ProBio Recent Developments
- 8.4 Creative Biolabs
- 8.4.1 Creative Biolabs Company Information
- 8.4.2 Creative Biolabs Business Overview
- 8.4.3 Creative Biolabs CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Creative Biolabs CAR-T Cell Service Product Portfolio
- 8.4.5 Creative Biolabs Recent Developments
- 8.5 Charles River Laboratories
- 8.5.1 Charles River Laboratories Company Information
- 8.5.2 Charles River Laboratories Business Overview
- 8.5.3 Charles River Laboratories CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Charles River Laboratories CAR-T Cell Service Product Portfolio
- 8.5.5 Charles River Laboratories Recent Developments
- 8.6 Cytiva
- 8.6.1 Cytiva Company Information
- 8.6.2 Cytiva Business Overview
- 8.6.3 Cytiva CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Cytiva CAR-T Cell Service Product Portfolio
- 8.6.5 Cytiva Recent Developments
- 8.7 Sino Biological, Inc
- 8.7.1 Sino Biological, Inc Company Information
- 8.7.2 Sino Biological, Inc Business Overview
- 8.7.3 Sino Biological, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Sino Biological, Inc CAR-T Cell Service Product Portfolio
- 8.7.5 Sino Biological, Inc Recent Developments
- 8.8 Miltenyi Biotec
- 8.8.1 Miltenyi Biotec Company Information
- 8.8.2 Miltenyi Biotec Business Overview
- 8.8.3 Miltenyi Biotec CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Miltenyi Biotec CAR-T Cell Service Product Portfolio
- 8.8.5 Miltenyi Biotec Recent Developments
- 8.9 ProMab Biotechnologies, Inc
- 8.9.1 ProMab Biotechnologies, Inc Company Information
- 8.9.2 ProMab Biotechnologies, Inc Business Overview
- 8.9.3 ProMab Biotechnologies, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.9.4 ProMab Biotechnologies, Inc CAR-T Cell Service Product Portfolio
- 8.9.5 ProMab Biotechnologies, Inc Recent Developments
- 8.10 Creative Biogene
- 8.10.1 Creative Biogene Company Information
- 8.10.2 Creative Biogene Business Overview
- 8.10.3 Creative Biogene CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Creative Biogene CAR-T Cell Service Product Portfolio
- 8.10.5 Creative Biogene Recent Developments
- 8.11 BPS Bioscience, Inc
- 8.11.1 BPS Bioscience, Inc Company Information
- 8.11.2 BPS Bioscience, Inc Business Overview
- 8.11.3 BPS Bioscience, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.11.4 BPS Bioscience, Inc CAR-T Cell Service Product Portfolio
- 8.11.5 BPS Bioscience, Inc Recent Developments
- 8.12 Reaction Biology
- 8.12.1 Reaction Biology Company Information
- 8.12.2 Reaction Biology Business Overview
- 8.12.3 Reaction Biology CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Reaction Biology CAR-T Cell Service Product Portfolio
- 8.12.5 Reaction Biology Recent Developments
- 8.13 Cusabio Technology LLC
- 8.13.1 Cusabio Technology LLC Company Information
- 8.13.2 Cusabio Technology LLC Business Overview
- 8.13.3 Cusabio Technology LLC CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Cusabio Technology LLC CAR-T Cell Service Product Portfolio
- 8.13.5 Cusabio Technology LLC Recent Developments
- 8.14 Oncodesign Services
- 8.14.1 Oncodesign Services Company Information
- 8.14.2 Oncodesign Services Business Overview
- 8.14.3 Oncodesign Services CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Oncodesign Services CAR-T Cell Service Product Portfolio
- 8.14.5 Oncodesign Services Recent Developments
- 8.15 ACROBiosystems
- 8.15.1 ACROBiosystems Company Information
- 8.15.2 ACROBiosystems Business Overview
- 8.15.3 ACROBiosystems CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.15.4 ACROBiosystems CAR-T Cell Service Product Portfolio
- 8.15.5 ACROBiosystems Recent Developments
- 8.16 Kite Pharma, Inc
- 8.16.1 Kite Pharma, Inc Company Information
- 8.16.2 Kite Pharma, Inc Business Overview
- 8.16.3 Kite Pharma, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Kite Pharma, Inc CAR-T Cell Service Product Portfolio
- 8.16.5 Kite Pharma, Inc Recent Developments
- 8.17 sartorius
- 8.17.1 sartorius Company Information
- 8.17.2 sartorius Business Overview
- 8.17.3 sartorius CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.17.4 sartorius CAR-T Cell Service Product Portfolio
- 8.17.5 sartorius Recent Developments
- 8.18 WuXi ATU Co
- 8.18.1 WuXi ATU Co Company Information
- 8.18.2 WuXi ATU Co Business Overview
- 8.18.3 WuXi ATU Co CAR-T Cell Service Revenue and Gross Margin (2021-2026)
- 8.18.4 WuXi ATU Co CAR-T Cell Service Product Portfolio
- 8.18.5 WuXi ATU Co Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst